Global fermentation technology leader GeneFerm Biotechnology continues to shine on the international stage. Two core ingredients developed through industry-academia collaboration with National Taiwan University—TestoPro^® Bacillus coagulans and AquaSoiivon^® Soy Extract Fermented Powder — both won gold awards at the 16th IIIC International Innovation and Invention Competition 2025, demonstrating the company’s research strength in functional mechanisms and patented production technologies.

GeneFerm Biotechnology stated that these awards not only recognize the R&D team’s long-term dedication to fermentation technology and biotransformation research but also highlight the company’s ability to successfully translate academic research into highly applicable raw materials, further enhancing the international visibility of Taiwan’s biotech ingredients.

AquaSoiivon^®：Patented ActiConvert^™ Technology Expands Water-Soluble Ingredient Applications

AquaSoiivon^® is a soy extract fermented powder developed by GeneFerm to address practical raw material application challenges. Compared to traditional soy isoflavone ingredients, which face formulation limitations, the R&D team leveraged the proprietary ActiConvert^™ biotransformation technology to modify molecular structures, providing excellent water dispersibility and enhancing flexibility for different dosage forms and product applications.

GeneFerm Biotechnology vice President Frank Hsiao noted that ActiConvert^™ technology is the result of years of research, effectively improving ingredient stability and processing flexibility in practical applications. This enables brand partners to explore more diverse formulation options for beverages, powders, and tablets.

Through this technology, AquaSoiivon^® is considered a highly suitable ingredient for products targeting middle-aged consumers and women’s nutritional supplements, helping brands develop product lines aligned with market trends.

TestoPro^®：Bacillus coagulans Research Supports Mechanism-Driven Ingredient Development

The other gold-winning ingredient, TestoPro^®, is a mechanism-driven raw material developed from Bacillus coagulans. Its R&D focuses on studying specific enzymes in live bacteria and exploring their potential in functional mechanism research through fermentation and process design.

Frank Hsiao emphasized that the development of TestoPro^® exemplifies GeneFerm Biotechnology’s core strengths in microbial research and integrated fermentation technology, providing new research directions and creative possibilities for functional ingredients in various nutritional supplement markets.

International Third-Party Recognition Supports Brand Market Positioning

GeneFerm Biotechnology noted that winning gold in the IIIC competition validates its leadership in both functional mechanism research and process technology transformation. This international recognition provides brand partners with highly credible third-party endorsement, supporting product development and market application evaluation, and helping brands establish professional trust in the highly competitive health supplement market.

(photo / AquaSoiivon^® Fermented Soy Extract and TestoPro^® Bacillus Coagulans
win Gold Awards at the 16th IIIC International Innovation and Invention Competition)